Drug–Target Kinetics in Drug Discovery-Reference-Cited by-同舟云学术

Drug–Target Kinetics in Drug Discovery

Published:2017-07-14 Issue:1 Volume:9 Page:29-39
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Tonge Peter J.¹^ORCID

Affiliation:

1. Institute for Chemical Biology & Drug Discovery, Departments of Chemistry and Radiology, Stony Brook University, Stony Brook, New York 11794-3400, United States

Funder

Genentech

Pharmaceutical Research and Manufacturers of America Foundation

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00185

Reference77 articles.

1. CNS Anticancer Drug Discovery and Development Conference White Paper

2. Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer

3. The Behavior and Significance of Slow-Binding Enzyme Inhibitors

4. Biochemical mechanisms of drug action: what does it take for success?

5. Drug–target residence time and its implications for lead optimization

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure–activity relationships;Bioorganic & Medicinal Chemistry;2024-09

2. Prediction of Threonine-Tyrosine Kinase Receptor-Ligand Unbinding Kinetics with Multiscale Milestoning and Metadynamics;2024-08-02

3. Ligand Gaussian Accelerated Molecular Dynamics 3 (LiGaMD3): Improved Calculations of Binding Thermodynamics and Kinetics of Both Small Molecules and Flexible Peptides;Journal of Chemical Theory and Computation;2024-07-13

4. High-throughput kinetics in drug discovery;SLAS Discovery;2024-07

5. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part I;Critical Reviews in Oncology/Hematology;2024-07